NTS-WBRT in Brain Metastases
A legfontosabb adatok
- Ki végzi
- Massachusetts General Hospital
- Hol
- Boston (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Fázis
- 2. fázis
- Résztvevők
- 41 fő, tervezett
- Kezdés
- 2022. febr. 8.
- Várható befejezés
- 2027. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- NTS-WBRT (normal tissue sparing whole brain radiation therapy)
- Memantine
- A regiszteradat frissítve
- 2026. április 16.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a solid tumor that has spread to the brain, who need whole brain radiation. It studies quality of life and symptoms after a brain radiation that spares normal tissue, given with memantine.
- Életkor
- 18 years or older.
- Nem
- All sexes can join.
- A betegség stádiuma
- Any number of brain metastases (cancer spread to the brain) from a solid tumor, needing whole brain radiation. Karnofsky Performance Status (a score of daily functioning) of 70 or more. Expected survival of more than 6 months.
- Korábbi kezelés
- Earlier focused radiation (SRS) or brain surgery may be allowed if the doctor agrees. Radiation starts at least 2 weeks after brain surgery. Earlier partial brain radiation is allowed if it covered less than 50% of the brain. People who had whole brain radiation before cannot join. Other cancer drugs before, during or after are allowed if the doctors agree.
- Biomarker vagy leletérték
- Women before menopause need a negative pregnancy test.
A részvétel fő kizáró okai
- Cancer spread to the lining of the brain and spinal cord (leptomeningeal disease).
- Earlier whole brain radiation.
- Past or current use of memantine or other NMDA antagonists.
- Allergy to MRI contrast or unable to have an MRI.
- Pregnancy, or not willing to use birth control during radiation.
A regiszter feltételei, szó szerint
Mind a 20 feltétel megnézéseKevesebb
Ki vehet részt
- Any patient with a solid tumor diagnosis and any number of brain metastasis clinically indicated for cranial irradiation with whole brain radiation therapy
- Age ≥ 18
- Karnofsky Performance Status ≥ 70
- Prior stereotactic radiosurgery (SRS) permissible per physician discretion
- Prior craniotomy permissible per physician discretion. Protocol radiation therapy should be initiated ≥2 weeks after craniotomy
- Prior partial brain radiation therapy permissible if target volume < 50% brain and per physician discretion
- Expectant > 6 months survival
- Ability to understand and the willingness to sign a written informed consent document
- Fluency in English, able to complete questionnaires and neurocognitive testing
- Ability to undergo MRI with gadolinium examination
- Ability to return for follow-up examinations throughout the course of this study for a maximum of 2 years after radiation treatment completion
- Any prior, concomitant, or post-radiotherapy systemic therapy is permitted at discretion of treating physicians
- Negative pregnancy test for premenopausal women
Ki nem vehet részt
- Prior whole brain radiation therapy
- Uncontrolled intercurrent illness that could significantly affect baseline cognitive function as determined by the enrolling clinician, such as symptomatic congestive heart failure, unstable angina pectoris, prior CVA, significant uncontrolled epilepsy or psychiatric illness/social situations that would limit compliance with study requirements
- Pregnant or unwilling to use appropriate contraception to prevent pregnancy during the time of radiation therapy
- Concurrent participation in an investigational systemic therapy protocol
- Leptomeningeal disease (by any one or more of clinical assessment, radiographic assessment, or cerebrospinal fluid study)
- Known allergy to contrast used in imaging studies and/or inability to have MRI imaging
- Pre-existing or current use of memantine or other NMDA antagonists
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- Massachusetts General Hospital Cancer CenterBoston, Egyesült ÁllamokContact: Helen A Shih, MD,MS,MPHRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
This research is being done to assess the quality of life and symptom burden in participants who receive (normal tissue sparing whole brain radiation therapy (NTS-WBRT).
A teljes eredeti leírásKevesebb
This research study involves:
* NTS-WBRT (normal tissue sparing whole brain radiation therapy) * Memantine standard of care drug
A vizsgálat csoportja
- NTS-WBRT (normal tissue sparing whole brain radiation therapy) + MemantineA vizsgált kezelés
Participants will be randomly assigned to NTS-WBRT (normal tissue sparing whole brain radiation therapy) administration group and receive: * NTS-WBRT for 5 days (Monday-Friday) for either 2 or 3 weeks. * Memantine per standard of care, 1-2x daily for up to 24 weeks Specific participant administration schedules will be determined by study doctor
Kezelés: NTS-WBRT (normal tissue sparing whole brain radiation therapy) és Memantine
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Phase II Trial of Normal Tissue Sparing Whole Brain Radiation Therapy (NTS-WBRT) in Patients With Brain Metastases
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
- A regiszteradat frissítve
- 2026. április 16.